Company News: Page (1) of 1 - 10/25/11 Email this story to a friend. email article Print this page (Article printing at page facebook

Analyst View, Impact of Global Events - Research Report on Cray Inc. and Adolor Corporation

(October 25, 2011)

HONG KONG -- (Marketwire) -- 10/25/11 -- Today, released its industry report highlighting Cray Inc. (NASDAQ: CRAY) and Adolor Corporation (NASDAQ: ADLR). Full fundamental and technical analysis is available at

Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets'.

As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.

Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.

World Street Fundamentals has highlighted Cray Inc. for its current position within the technology industry. Cray Inc., incorporated in December 1987, designs, develops, manufactures, markets and services high-performance computing (HPC) systems, known as supercomputers and provides engineering services related to HPC systems and solutions. The entire report on Cray Inc. (NASDAQ: CRAY) is available here:

World Street has featured Adolor Corporation for its development within the healthcare industry. Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain-management products. ENTEREG (alvimopan) is the United States Food and Drug Administration (FDA) approved product. The entire report on Adolor Corporation (NASDAQ: ADLR) is available here:

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.


Adam Redford
Email Contact

Copyright @ Marketwire

Page: 1

Related Keywords: World Street Fundamentals, USA, Marketwire, Inc., , Financial, Medical,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved